Literature DB >> 19684371

Genetic counseling for thalassemia in the Islamic Republic of Iran.

Bernard S Strauss1.   

Abstract

The response of groups to pressing medical problems cannot be predicted on theoretical grounds. An example is the program for the control of beta-thalassemia in Iran, a country with a tradition of inbreeding and a conservative religious culture, and in which thalassemia is common. Thalassemia is largely treatable, but the treatment is lifelong and onerous and creates a serious economic burden for the individual family and for the national health budget. The genetics are simple, and inexpensive screening tests are available to identify carriers. An Iranian program requiring mandatory premarital screening was started in 1997, and between 1998 and 2005 the laws of the country were modified to permit abortion of affected fetuses. The story of this effort indicates how a country with a social system very different from that of the United States responded to a medical problem with significant ethical overtones. The Iranian experience supports the optimistic view that societies can react to pressing problems with pragmatic rather than theoretical solutions.

Entities:  

Mesh:

Year:  2009        PMID: 19684371     DOI: 10.1353/pbm.0.0093

Source DB:  PubMed          Journal:  Perspect Biol Med        ISSN: 0031-5982            Impact factor:   1.416


  7 in total

1.  Effects of a genetic counseling model on mothers of children with down syndrome: a Brazilian pilot study.

Authors:  Marcos Ricardo Datti Micheletto; Nelson Iguimar Valerio; Agnes Cristina Fett-Conte
Journal:  J Genet Couns       Date:  2013-06-23       Impact factor: 2.537

2.  At-risk marriages after compulsory premarital testing and counseling for β-thalassemia and sickle cell disease in Saudi Arabia, 2005-2006.

Authors:  Fahad M Alswaidi; Ziad A Memish; Sarah J O'Brien; Nasser A Al-Hamdan; Faisal M Al-Enzy; Osamah A Alhayani; Ali M Al-Wadey
Journal:  J Genet Couns       Date:  2011-08-09       Impact factor: 2.537

3.  Effect of hepatic iron concentration and viral factors in chronic hepatitis C-infected patients with thalassemia major, treated with interferon and ribavirin.

Authors:  Maryam Jafroodi; Ramin Asadi; Abtin Heydarzadeh; Sepiedeh Besharati
Journal:  Int J Gen Med       Date:  2011-07-13

Review 4.  Genetic epidemiology, hematological and clinical features of hemoglobinopathies in Iran.

Authors:  Zohreh Rahimi
Journal:  Biomed Res Int       Date:  2013-06-18       Impact factor: 3.411

5.  Haplotypes inside the beta-globin gene: use as new biomarkers for beta-thalassemia prenatal diagnosis in north of Iran.

Authors:  Mohammad Bagher Hashemi-Soteh; Seyed Saeed Mousavi; Alireza Tafazoli
Journal:  J Biomed Sci       Date:  2017-12-04       Impact factor: 8.410

6.  Prevalence and Genetic Analysis of α- and β-Thalassemia and Sickle Cell Anemia in Southwest Iran.

Authors:  Forozan H Nezhad; Khojasteh H Nezhad; Parastoo M Choghakabodi; Bijan Keikhaei
Journal:  J Epidemiol Glob Health       Date:  2018-12

Review 7.  Hemoglobinopathies in Iran: An Updated Review.

Authors:  Abolfazl Nasiri; Zohreh Rahimi; Asad Vaisi-Raygani
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2020-04-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.